Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: EC:6.2.1.1 (ACS)
 78,556 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

The remediation of soil contaminated by 1,1,1-trichloro-2,2-bis(4-chlorophenyl) ethane (DDT) has been a challenge. In this paper, the degradation performances of the ball milling-induced plate-like sub-microstructured zero valent iron (SMZVI) to DDT in a real soil environment is studied. It has been found that such SMZVI exhibits much higher degradation performances to DDT in soil than commercial ZVI powders under acidic conditions. More than 95% DDT could be degraded within 80 min in the 5 ppm DDT-contaminated soil with addition of 50 mg g-1 SMZVI, which is much better than the previously reported results. The time-dependent DDT removal amount can be well described by the pseudo first-order kinetic model. Further experiments have revealed that the ZVI dosages, surfactant's and acidic additions, and the weight ratio of soil-to-water in the slurries are important to DDT degradation, and the degradation products were mainly DDD (a product with less chlorine). An acid-assisted ZVI-induced reductive dechlorination process is proposed, which can well explain the DDT degradation behaviors in soil and the influence from the other factors. This work not only deepens the understanding of DDT degradation in soils based on ZVI but also demonstrates that the SMZVI could be a promising material for DDT degradation in real environments.
ACS Omega 2018 Jun 30
PMID:Ball Milling-Induced Plate-like Sub-microstructured Iron for Enhancing Degradation of DDT in a Real Soil Environment. 3145 61

Gliomas-devastating intracranial tumors with a dismal outcome-are in dire need of innovative treatment. Although nanodrugs have been utilized as a target therapy for certain types of solid tumors, their therapeutic effects in gliomas are limited due to the complications of the systemic circulation, blood-brain barrier (BBB), and specific glioma environment. Thus, we aimed to establish a nanoliposome adaptable to different environments by codelivery of shCD163 and doxorubicin (DOX) to treat gliomas. In this study, we first synthesized pH-sensitive DSPE-cRGD-Hz-PEG2000 to form an environmentally self-adaptative nanoliposome (cRGD-DDD Lip) via a thin film method. We used in vitro BBB models, in vitro cell uptake experiments, and in vivo biodistribution assays to confirm the long circulation time and low cell uptake of the cRGD-DDD Lip as a result of the poly(ethylene glycol) (PEG) shell of cRGD-DDD Lip in the neutral pH systemic circulation. Moreover, the cRGD-DDD Lip bypassed the BBB and attached to the intracranial glioma following the removal of the PEG shell and the exposure of cRGD to the weakly acidic tumor microenvironment. We further assembled the shCD163/DOX@cRGD-DDD Lip through cRGD-DDD Lip loading of shCD163 and DOX. In vitro, cell proliferation and self-renewal of glioma cells were inhibited by the shCD163/DOX@cRGD-DDD Lip due to the toxicity of DOX and the suppression of shCD163 via the CD163 pathway. In vivo, the shCD163/DOX@cRGD-DDD Lip disturbed the progression of in situ gliomas by inhibiting the growth and stemness of glioma cells and prevented the recurrence of gliomas after resection. In conclusion, the cRGD-DDD Lip may be a promising nanodrug-loading platform to cope with different environments and the shCD163/DOX@cRGD-DDD Lip may potentially be a novel nanodrug for glioma therapy.
ACS Appl Mater Interfaces 2020 Nov 25
PMID:Environmentally Self-Adaptative Nanocarriers Suppress Glioma Proliferation and Stemness via Codelivery of shCD163 and Doxorubicin. 3319 79